TLDR summary of PIONEER 4 & 6 trials: The oral semaglutide 14mg group achieved a 1.2% reduction in HbA1c and 4.3kg of weight loss, outperforming the liraglutide group
After one month, your doctor will increase your dose to 7 mg once a day
Safety of semaglutide treatment Risk of thyroid cancer According to recent research from the GAROS study, semaglutide may have an impact on thyroid hormones, such as free triiodothyronine (fT3), free thyroxine (fT4), and thyroid-stimulating hormone (TSH)
Rates were higher than previously reported for GLP-1 mono agonists (semaglutide) and dual agonists (tirzepatide), which is consistent with a stronger overall incretin load
The result: people and animals eat less because they genuinely feel fuller, not because they're willpower-deprived
First, define "not working" Give tirzepatide a fair trial